Meredith Pelster, MD

Meredith Pelster, MD is a part of SCRI Oncology Partners, a leading institution in oncology research located at 335 24th Avenue North, Nashville, Tennessee. With a focus on providing advanced cancer care and conducting clinical trials through their affiliation with Sarah Cannon Research Institute, SCRI Oncology Partners offers personalized treatment options for various types of cancer, including breast, lung, melanoma, and more. Led by internationally recognized experts like Meredith S. Pelster, MD, the institution is dedicated to bringing groundbreaking therapies to the community and reducing inpatient hospital admissions and emergency department visits. With a focus on chemotherapy, immunotherapies, and clinical trials, SCRI Oncology Partners is committed to providing the latest treatment options for individuals facing cancer. To schedule an appointment or learn more, contact them at 615-329-7640 or email cancercareSCRI@usoncology.com.